retatrutide weight loss study Results: How Much Can You Lose & How Quick? What Is Retatrutide? Side Effects,

This changes the conversation completely

What the Studies Actually Showed: Preclinical Data Study 1: Fat and Liver Mass Drop Far Faster Than Muscle In diet-induced obese mice treated with tirzepatide (the dual GLP-1/GIP agonist in Mounjaro and Zepbound) for 14 days, researchers found a 73% reduction in body fat and only a 13% reduction in LBM

Obtaining definitive proof of synapses would require systematic reconstruction using serial electron microscopy on a large population of enteroendocrine cells

Conversely, although off-label use of GLP-1 RA for overweight and obesity cannot be excluded, such use was likely limited in the present study given existing prescription guidelines and regulatory vigilance

Subcutaneous injection in the abdomen (at least two inches away from the navel), the front of the thigh, or the back of the upper arm